| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |